FDA's enforcement report lists a Class II recall of vasopressin in 0.9% sodium chloride, 40 units per 100 mL, from Baxter Healthcare, dated 9 September and ongoing. The stated reason is deviations from current good manufacturing practice.
Class II means use may cause temporary or reversible harm, or serious harm is remote. The record reports no patient injury and lists no lots. Premixed vasopressin is used in septic shock; this is a US product and its availability in India is not stated.
- Ask pharmacy to check premixed vasopressin stock against the FDA listing.
- Keep a compounded vasopressin infusion protocol available.
- No change to vasopressor strategy in septic shock is implied.
Why it matters
Premixed vasopressor supply affects how quickly second-line support can start in septic shock.
Don't overread it
A manufacturing-practice recall is not a report of patient harm.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for emergency & critical care, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free